Presentation ESC 2014 Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry Presenter: Eric Van Belle September 02, 2014
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Conference News ESC 2014 GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 Another Strike Against Thrombectomy in 1-Year TASTE Results Todd Neale September 02, 2014
Presentation ESC 2014 10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial Presenter: Robert A. Henderson September 02, 2014
News Conference News ESC 2014 SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year Todd Neale September 01, 2014
Presentation ESC 2014 Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization Presenter: Thomas Pilgrim September 01, 2014
News Conference News ESC 2014 NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin Caitlin E. Cox September 01, 2014
News Conference News ESC 2014 FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI Todd Neale September 01, 2014
News Conference News ESC 2014 CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients Caitlin E. Cox September 01, 2014
News Conference News ESC 2014 BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial Yael L. Maxwell September 01, 2014
News Conference News ESC 2014 ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration Yael L. Maxwell September 01, 2014
News Conference News ESC 2014 SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS Yael L. Maxwell August 31, 2014
News Conference News ESC 2014 Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis Caitlin E. Cox August 31, 2014
News Conference News ESC 2014 Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device Todd Neale August 31, 2014
News Conference News ESC 2014 Observational Studies Ask How Much Medication Adherence Matters After MI Caitlin E. Cox August 31, 2014
News Conference News ESC 2014 APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI Yael L. Maxwell August 31, 2014